home / stock / crmd / crmd news


CRMD News and Press, CorMedix Inc.

Stock Information

Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NASDAQ
Website: cormedix.com

Menu

Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...

CRMD - As U.S. profit margins near record highs, these small-cap stocks lead on profitability

2026-06-18 07:43:44 ET More on small cap stocks June FOMC Statement: Contrarian Perspective On The Expected Rate Hike Hawkish-Leaning Committee, Reform-Minded Chair: Warsh's First Fed Meeting 'Regime Change; At The Fed: Fed Chair Warsh Makes The First Moves U...

CRMD - These small-cap healthcare stocks pair revenue growth with attractive valuations

2026-06-17 07:02:05 ET More on Health Care stocks IHI: Pressured Consumers, Unclear Healthcare Policy, Weak Price Action AI Revolutionizing Biopharma: Faster, Better, Cheaper Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit Weekly ETFs...

CRMD - U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

PARSIPPANY, N.J., June 08, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that the United States Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the Northern District of Illinois that the patents covering its product...

CRMD - These 10 small-cap U.S. healthcare giants rank among the market's most attractively valued stocks

2026-06-01 10:20:19 ET More on AdaptHealth Corp., Community Health Systems, etc. ADMA Biologics: Longstanding Bull Hits The Reset Button After Murky Q1 Earnings CorMedix: Bleak Short-Term Outlook, But Significantly Undervalued For The Long Run Rigel Pharmaceuticals, ...

CRMD - CorMedix: Bleak Short-Term Outlook, But Significantly Undervalued For The Long Run

2026-05-27 13:36:18 ET Article Thesis CorMedix Inc. ( CRMD ) is one of my worst-performing positions for now, at least since I've been writing for Seeking Alpha (September-October 2024). With a cost average of $10.8, I am sitting on an ~24% loss (position initiated in June l...

CRMD - CorMedix: Long-Term Prospects Remain Poor Despite Q1 Beat

2026-05-18 10:09:15 ET CorMedix Overview My last evaluation of CorMedix’s stock ( CRMD ) was earlier this year in January. I downgraded the stock from Hold to Sell . At this time, the company's main product, DefenCath, was facing reimbursement headwinds. And I didn't ...

CRMD - Cormedix Therapeutics to Participate in two Upcoming Investor Conferences

PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and...

CRMD - CorMedix (CRMD) Q1 2026 Earnings Transcript

2026-05-14 14:44:47 ET Image source: The Motley Fool. Thursday, May 14, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

CRMD - Cormedix outlines $325M-$345M 2026 net revenue outlook amid TDAPA transition

2026-05-14 12:41:53 ET More on CorMedix CorMedix Inc. (CRMD) Q1 2026 Earnings Call Transcript CorMedix: A Shrinking Core And No Proven Second Engine CorMedix: Waiting On Phase III ReSPECT For A Further Re-Rating (Upgrade) CorMedix beats top-line and bottom-li...

CRMD - CorMedix Inc. (CRMD) Q1 2026 Earnings Call Transcript

2026-05-14 12:40:44 ET CorMedix Inc. (CRMD) Q1 2026 Earnings Call May 14, 2026 8:30 AM EDT Company Participants Joseph Todisco - CEO & Chairman of the Board of Directors Elizabeth Masson-Hurlburt - Executive VP, Chief Operating Officer & Chief Integration Officer...

Next 10